Investors in Finance

ROCH Ventures is a Luxembourg-based VC fund investing in Travel & Hospitality Tech startups in Europe, driving innovation in the sector with a focus on modern traveler preferences and cutting-edge technologies.

Oxx is a dynamic growth capital investment firm based in London and Stockholm. Specializing in backing B2B software companies at the scale-up stage, Oxx focuses on investing in businesses that demonstrate strong market potential and sustainable growth. The firm's approach combines deep sector expertise with operational support, aiming to help portfolio companies achieve their full potential. Oxx is committed to partnering with ambitious entrepreneurs and supporting them in navigating the challenges of scaling their businesses. By fostering innovation and entrepreneurship in the B2B software sector, Oxx contributes to driving meaningful advancements and transformations in industry-specific technologies.

We strive to contribute to a better life for people around the world by supporting entrepreneurs at the beginning of their journey to create breakthrough technologies. Investor at the seed stage of start-ups in the field of internet and mobile technologies.

Ambrosia Investments is an investment firm focused on providing growth capital for disruptive brands and businesses in the food, beverage and ingredients industries. Ambrosia looks to bring entrepreneurial experience and advice to its portfolio companies, while also maintaining a long-term perspective. Ambrosia is focused on minority growth capital investments in primarily Europe and the United States, with a sweet spot investment size range of €2 to €20 million per deal.

Save Company Founded by incredibly skilled and complementary business leaders, Una Terra is a venture capital fund, complemented by a venture studio, providing capital, network & support to accelerate growth and impact of emerging ESG enterprises. Growth capital > Series A and later - 10M avg ticket per company Our mission is to become a sparring-partner and continuously help the business on the product, go-to-market, business development and talent acquisition.

Stride.VC is a specialized venture capital firm targeting seed stage startups primarily in the UK and France. They focus on investing in early-stage companies with promising innovations and strong growth prospects. Stride.VC provides essential capital and strategic support to help startups navigate their initial growth phases and scale efficiently. With a keen eye for identifying market opportunities, they partner closely with visionary founders to build sustainable and impactful businesses. Stride.VC leverages its extensive network and sector expertise to drive value creation and foster entrepreneurial success within the dynamic startup ecosystems of the UK and France.

i&i Bio is a Luxembourg-based venture capital firm that invests in innovative European Life Sciences companies focused on drug discoveries, medical devices, diagnostics and digital health. With over €53M under management, i&i Bio plans to invest in about 20 early-stage companies. i&i Bio is led by an experienced team of professionals with backgrounds in private equity, the healthcare industry and venture capital who support entrepreneurs on their journey to global success. Thanks to close cooperation with the fund's main sponsor, the biotech academic incubator, i&i Prague, i&i Bio has a great opportunity to be at the inception of transformative Central European technologies.

Waarde Capital is an investment company founded by entrepreneurs for entrepreneurs. As such, we are well positioned to identify and support best companies with strong entrepreneurs. With three active funds under management, including LBO, growth equity, and venture fund, we can invest practically on every stage of the business lifecycle, and do it globally. Waarde invests in Europe, US, Israel, Russia, and Southeast Asia.

Systemiq Capital is an investment firm focused on driving systemic change towards a sustainable future. They invest in sectors critical to addressing global challenges, including sustainable food & materials, clean transport, climate intelligence & finance, and climate restoration. Systemiq Capital partners with innovative companies and entrepreneurs who are developing solutions that mitigate climate change, promote sustainable development, and create positive environmental impact. By combining investment expertise with a commitment to sustainability, Systemiq Capital aims to catalyze transformative change and contribute to building a resilient and low-carbon economy.

DIP Capital is a venture capital firm focused on investing across Europe in disruptive businesses. They specialize in identifying and supporting innovative startups that have the potential to transform their industries. DIP Capital provides strategic capital, operational expertise, and industry connections to help these businesses scale and achieve market leadership. With a commitment to fostering entrepreneurship and innovation, DIP Capital plays a crucial role in supporting founders and driving growth in Europe's dynamic startup ecosystem. Their investment strategy aims to capitalize on emerging trends and disruptive technologies, creating value for both investors and portfolio companies alike.

Phi Square Holdings SA is a proprietary investment company based in Luxembourg. As investors, we are following strategies which offer high growth potential while displaying low correlation to global markets; strategies that do not yet, or may no longer, attract mass capital.

GM&C Life Sciences Fund specializes in providing venture capital funds to entrepreneurs operating in the life sciences sector. The fund focuses on supporting innovative startups and companies that are developing breakthrough technologies and solutions in areas such as biotechnology, pharmaceuticals, medical devices, and healthcare services. GM&C Life Sciences Fund aims to accelerate the growth and commercialization of promising life sciences ventures by offering strategic capital, industry expertise, and networking opportunities. The fund plays a crucial role in advancing cutting-edge research and development efforts that have the potential to transform healthcare and improve patient outcomes globally.